LINC00511 and prostate carcinoma: After elucidating the expression patterns of LINC00673 and LINC00673, we treated the prostate cancer cell lines DU145 and PC3 with si‐NC and si‐LINC00673 to conduct a series of assays to verify the effects of LINC00673 on prostate cancer cell proliferation.